Calcifediol (25-Hydroxyvitamin D3) in the Treatment of Uremic Bone Disease

This publication has 17 references indexed in Scilit:

• Is Calcitriol [1,25(OH)2D3] Harmful to Renal Function?
  Published by American Medical Association (AMA) ,1979
• DETERIORATION OF RENAL FUNCTION DURING TREATMENT OF CHRONIC RENAL FAILURE WITH 1,25- DIHYDROXYCHOLECALCIFEROL
  The Lancet, 1978
• The Efficacy of Calcifediol in Renal Osteodystrophy
  Archives of internal medicine (1960), 1978
• The effect of 1α(OH)D3 and 1α,25(OH)2D3 on the bone in patients with renal osteodystrophy
  The American Journal of Medicine, 1978
• Tetracycline fluorescence in uremic and primary hyperparathyroid bone
  Kidney International, 1977
• VARIABLE RESPONSE TO LONG-TERM 1α-HYDROXYCHOLECALCIFEROL IN HÆMODIALYSIS OSTEODYSTROPHY
  The Lancet, 1976
• CONTROLLED TRIAL OF 1α-HYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILURE
  The Lancet, 1976
• Calcifediol in Chronic Renal Insufficiency
  Published by American Medical Association (AMA) ,1976
• Hyperparathyroid bone disease in children undergoing long-term hemodialysis; treatment with vitamin D
  The Journal of Pediatrics, 1974
• Action of 1,25-Dihydroxycholecalciferol, a Potent, Kidney-Produced Metabolite of Vitamin D₃, in Uremic Man
  New England Journal of Medicine, 1972